Suven Pharmaceuticals' Stock Sees Decline, But Remains Strong in Pharmaceutical Industry

Suven Pharmaceuticals, a leading player in the pharmaceuticals and drugs industry, has recently seen a decline in its stock price. On November 12, 2024, the company's stock lost -4.13%, underperforming the sector by -3.63%. This has led to a 'Hold' call for the stock by MarketsMOJO.

The stock has been on a downward trend for the past 5 days, with a consecutive fall of -9.87% in returns during this period. On the same day, the stock touched an intraday low of Rs 1199.15, a decrease of -4.28%. However, the stock's moving averages are still higher than the 100-day and 200-day moving averages, but lower than the 5-day, 20-day, and 50-day moving averages.

In comparison to the overall market performance, Suven Pharmaceuticals' stock has underperformed. On the day of the decline, the stock's performance was -4.19% compared to the Sensex's -1.08%. Over the past month, the stock has seen a slight increase of 0.07%, while the Sensex has seen a decline of -3.37%.

Despite the recent decline in stock price, Suven Pharmaceuticals remains a largecap company in the pharmaceuticals and drugs industry. With its strong presence in the market and consistent performance, the company continues to be a key player in the industry.